There are more than 400 drug candidates in development for Diabetes
With more than 400 drug candidates for diabetes in active development
and in light of the recent US Food and Drug Administration (FDA) guidance
to assess cardiovascular risk in clinical trials, the burden to develop novel drugs
is greater and the barrier for success has become higher than ever.
and in light of the recent US Food and Drug Administration (FDA) guidance
to assess cardiovascular risk in clinical trials, the burden to develop novel drugs
is greater and the barrier for success has become higher than ever.